NCT04429191 2021-06-11JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell TransplantationJasper Therapeutics, Inc.Phase 1 Unknown40 enrolled